Ultimovacs ASA (ULTI.OL) - Stock Prices, Stock Peers & Analysis

Home
ULTI.OL

Company Name	Ultimovacs ASA
Symbol	ULTI.OL
Currency	NOK
Price	107.4
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	3,694,184,100
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	67.9 - 178.6
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Carlos de Sousa
Website	https://ultimovacs.com

An error occurred while fetching data.

About Ultimovacs ASA

Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.